Microvascular dysfunction in normotensive, normoalbuminuric, normo- or hyperfiltrate type 2 diabetes

Renal Failure

Volumn 35, Issue 8, 2013, Pages 1191-1192

  Futrakul, Narisa ^a   Chaisuriya, Papada ^b   Ratanabanangkoon, Kavi ^b   Futrakul, Prasit ^c  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b CHULABHORN RESEARCH INSTITUTE   (Thailand)

^c Bhumirajanagarindra Kidney Institute   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOSTATIN; ENDOTHELIN 1; NITRIC OXIDE;

CAPILLARY FLOW; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; GLYCEMIC CONTROL; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY PLASMA FLOW; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ULTRAFILTRATION;

DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HUMANS; MICROVESSELS;

EID: 84881570829     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.819728     Document Type: Letter

References (11)

1. Futrakul N, Futrakul P. Vascular homeostasis and angiogenesis determine therapeutic effectiveness in type 2 diabetes. Internat J Vasc Med. 2011; 2011: Article ID 971524. doi: 10.1155/2011/971524.
2. Futrakul N, Futrakul P. Normalization of kidney dysfunction in normotensive, normoalbuminuric type 2 diabetes. Ren Fail. 2013; 35(7): 1058-1059.
3. Futrakul N, Kulapatana O, Futrakul P, et al. Enhanced peritubular capillary flow and renalfunction can be accomplished in normoalbuminuric type 2 diabetic nephropathy. Ren Fail. 2011; 33: 312-315.
4. Remuzzi G, Macia M, Ruggenenti P. Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study. J Am Soc Nephrol. 2006; 17: S90-S97.
5. Futrakul P, Yenrudi S, Futrakul N, et al. Tubular function and tubulointerstitial disease. Am J Kidney Dis. 1999; 33: 886-891.
6. Montanari A, Pela G, Musirri L, et al. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type-1 diabetes. Am J Physiol Renal Physiol. 2013; 305(1): F42-F51.
7. Ustandag B, Canatan H, Cinkilinc N, et al. Angiotensin converting enzyme (ACE) activity levels in insulin - independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy. Cell Biochem Funct. 2000; 18: 23-28.
8. Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag. 2008; 4: 1061-1068.
9. Futrakul N, Butthep P, Laohareungpanya N, et al. A defective angiogenesis in chronic kidney disease. Ren Fail. 2008; 30(2): 215-217.
10. Palatini P. Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension. Nephrol Diab Transplant. 2012; 27(5): 1708-1714.
11. Hilgers Karl F, Veelken R. Type 2 diabetic nephropathy: never too early to treat? J Am Soc Nephrol. 2005; 16: 574-575.